Vestavia Hills, AL, United States of America

Minwan Wu

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 6.0

ph-index = 9

Forward Citations = 392(Granted Patents)


Location History:

  • Birmingham, AL (US) (2011 - 2013)
  • Vestavia Hills, AL (US) (2008 - 2024)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
28 patents (USPTO):

Title: Minwan Wu: A Trailblazer in Patent Innovation

Introduction: Minwan Wu, based in Vestavia Hills, Alabama, is an accomplished inventor with an impressive portfolio of 27 patents. His contributions to the field of pharmaceutical innovation have established him as a significant figure in his industry.

Latest Patents: Among his latest achievements are the patents related to human plasma kallikrein inhibitors, where he has disclosed various compounds of formula I. These innovations play a crucial role in the development of new therapeutic agents, showcasing his expertise in medicinal chemistry and drug discovery.

Career Highlights: Minwan Wu has had a remarkable career marked by his time at Biocryst Pharmaceuticals, Inc. His work at this leading biotechnology company has centered around discovering and developing groundbreaking treatments, making significant strides in the fight against various diseases.

Collaborations: Throughout his career, Minwan Wu has collaborated with several noteworthy colleagues, including Pravin L. Kotian and V. Satish Kumar. These collaborations have fostered a rich environment for innovation and have contributed to several successful patent applications.

Conclusion: With his extensive portfolio and collaborative spirit, Minwan Wu continues to push the boundaries of pharmaceutical innovation. His contributions not only enhance our understanding of complex diseases but also pave the way for future therapeutic advancements. As he moves forward in his career, the industry eagerly anticipates his next innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…